Terms: = Ovarian cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR
55 results:
1. MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous ovarian cancer.
Flores-Colón M; Rivera-Serrano M; Reyes-Burgos VG; Rolón JG; Pérez-Santiago J; Marcos-Martínez MJ; Valiyeva F; Vivas-Mejía PE
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612604
[TBL] [Abstract] [Full Text] [Related]
2. foxo1 promotes ovarian cancer by increasing transcription and METTL14-mediated m
Tan L; Wang S; Huang S; Tie Y; Sai N; Mao Y; Zhao S; Hou Y; Dou H
Cancer Sci; 2024 Apr; 115(4):1224-1240. PubMed ID: 38403332
[TBL] [Abstract] [Full Text] [Related]
3. Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses.
Guo Y; Li S; Li C; Wang L; Ning W
Front Immunol; 2023; 14():1326018. PubMed ID: 38143770
[TBL] [Abstract] [Full Text] [Related]
4. Sertoli Cell-Specific Activation of Transforming Growth Factor Beta Receptor 1 Leads to Testicular Granulosa Cell Tumor Formation.
Fang X; Nie L; Putluri S; Ni N; Bartholin L; Li Q
Cells; 2023 Nov; 12(23):. PubMed ID: 38067144
[TBL] [Abstract] [Full Text] [Related]
5. RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
6. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
[TBL] [Abstract] [Full Text] [Related]
7. Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles.
Hirano T; Arai E; Fujimoto M; Nakayama Y; Tian Y; Ito N; Makabe T; Yamagami W; Susumu N; Aoki D; Kanai Y
J Gynecol Oncol; 2022 Nov; 33(6):e74. PubMed ID: 36047377
[TBL] [Abstract] [Full Text] [Related]
8. HB-EGF induces mitochondrial dysfunction via estrogen hypersecretion in granulosa cells dependent on cAMP-PKA-JNK/ERK-Ca
Huang JC; Duan CC; Jin S; Sheng CB; Wang YS; Yue ZP; Guo B
Int J Biol Sci; 2022; 18(5):2047-2059. PubMed ID: 35342363
[TBL] [Abstract] [Full Text] [Related]
9. Scutellarein induces apoptosis and inhibits proliferation, migration, and invasion in ovarian cancer via inhibition of EZH2/foxo1 signaling.
Lang X; Chen Z; Yang X; Yan Q; Xu M; Liu W; He Q; Zhang Y; Cheng W; Zhao W
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22870. PubMed ID: 34350670
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of c-Myc using 10058-F4 induces anti-tumor effects in ovarian cancer cells via regulation of FOXO target genes.
Ghaffarnia R; Nasrollahzadeh A; Bashash D; Nasrollahzadeh N; Mousavi SA; Ghaffari SH
Eur J Pharmacol; 2021 Oct; 908():174345. PubMed ID: 34270986
[TBL] [Abstract] [Full Text] [Related]
11. Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer.
Shi YY; Meng XT; Xu YN; Tian XJ
J Obstet Gynaecol Res; 2021 Jun; 47(6):1946-1957. PubMed ID: 33827148
[TBL] [Abstract] [Full Text] [Related]
12. foxo1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract] [Full Text] [Related]
13. Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines.
Fabi F; Adam P; Parent S; Tardif L; Cadrin M; Asselin E
Mol Oncol; 2021 Aug; 15(8):2106-2119. PubMed ID: 33338300
[TBL] [Abstract] [Full Text] [Related]
14. Aldosterone from endometrial glands is benefit for human decidualization.
Li SY; Song Z; Yan YP; Li B; Song MJ; Liu YF; Yang ZS; Li MY; Liu AX; Quan S; Yang ZM
Cell Death Dis; 2020 Aug; 11(8):679. PubMed ID: 32826848
[TBL] [Abstract] [Full Text] [Related]
15. An integration analysis of mRNAs and miRNAs microarray data to identify key regulators for ovarian endometriosis based on competing endogenous RNAs.
Wang K; Sun Y; Wang Y; Liu L
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():468-475. PubMed ID: 32738676
[TBL] [Abstract] [Full Text] [Related]
16. foxo1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.
Liu L; Yi J; Yuan J; Yao T; Lin Z; Ning Y; Zeng Z
Cancer Biomark; 2020; 28(1):1-8. PubMed ID: 32224523
[TBL] [Abstract] [Full Text] [Related]
17. Overexpressed ITGA2 contributes to paclitaxel resistance by ovarian cancer cells through the activation of the AKT/foxo1 pathway.
Ma L; Sun Y; Li D; Li H; Jin X; Ren D
Aging (Albany NY); 2020 Mar; 12(6):5336-5351. PubMed ID: 32202508
[TBL] [Abstract] [Full Text] [Related]
18. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
Gong G; Lin T; Yuan Y
J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
[TBL] [Abstract] [Full Text] [Related]
19. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic implications of forkhead box protein O1 (foxo1) and paired box 3 (PAX3) in epithelial ovarian cancer.
Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
[TBL] [Abstract] [Full Text] [Related]
[Next]